Work

Immune Response of Hepatitis B Vaccine Among Persons With Diabetes

Year: 2012
Type: review
Abstract: cination for adults with diabetes in the United States (1). Serosurvey data from the 1999–2010 National Health and Nu-trition Examination Survey found that noninstitutionalized adults aged $18 years with diabetes have an increased se-roprevalence of past or current hepatitis B virus (HBV) infection (1). Outbreaks of hepatitis B in elderly persons with diabe-tes in long-term care facilities have been linked to diabetes care procedures (in-cluding blood glucose monitoring), with likely vehicles for transmission including spring-loaded finger-stick devices used on multiple patients and blood glucose testing meters that were not cleaned be-tween uses on different patients. In the U.S., hepatitis B vaccination is routinely recommended for infants, chil-dren, and adolescents. It also is recom-mended for adults at increased risk of HBV infection, including persons with end-stage renal disease or chronic liver disease, health care personnel, injection-drug users, and men who have sex with men (2–4). A hepatitis B vaccination se-ries results in protection in a high propor-tion (.95%) of infants, children, and young adults (5). As with other vaccines, the efficacy of the hepatitis B vaccine pro-gressively declines with advancing age, as well as with the presence of obesity and other comorbid conditions (6–12). Results of studies of the hepatitis B vac-cine among persons with diabetes gener-ally follow these patterns (13,14). Primary hepatitis B vaccination usu-ally consists of 3 (or 4) doses of 10 or 20 mg of recombinant hepatitis B surface antigen (HBsAg) protein administered in-tramuscularly into the deltoid muscle on a 0-, 1-, and 6-month schedule (Table 1). Alternative schedules are U.S.-approved for routine vaccination for spe-cific ages and vaccine formulations, and they elicit dose-specific and final rates of seroprotection similar to those obtained on a 0-, 1-, and 6-month schedule (4). Two single-antigen recombinant vac-
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2115705306
FWCI: 0.454
Cites: 59
Cited by: 97
Related to: 9